Ethics and Specific IFRS Applications

SECTION A NeuroTech Solutions (NTS) is a fast-growing technology startup specializing in artificial intelligence. NTS is currently preparing its financial statements for the year ended 31 December 20X5, ahead of a planned Initial Public Offering (IPO) in mid-20X6. During the year, NTS incurred $8 million in costs developing a new predictive AI algorithm. The project began in January 20X5, but technical feasibility and the ability to generate future economic benefits were only established on 1 November 20X5. Costs incurred from 1 November to 31 December 20X5 amounted to $1.5 million. The CFO has instructed the financial controller, who is an ACCA member, to capitalize the entire $8 million as an intangible asset, stating: 'We need our balance sheet to look as strong as possible for the IPO investors. Everyone knows this algorithm is our golden ticket.' Additionally, NTS signed several three-year Software-as-a-Service (SaaS) contracts with clients in December 20X5, receiving $3 million upfront. The CFO has directed that this entire $3 million be recognized as revenue in the 20X5 financial statements to boost the current year's earnings. Required: (a) Discuss the correct accounting treatment for the AI algorithm development costs and the SaaS revenue contracts under IFRS Accounting Standards for the year ended 31 December 20X5. (12 marks) (b) Discuss the ethical and professional implications for the financial controller regarding the CFO's instructions, and recommend the actions the financial controller should take in accordance with the ACCA Code of Ethics and Conduct. (8 marks)